Announcements Trials
Browse Landscape

Phase

Phase 1 2

Status

Recruiting 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

CNS 2

Conditions

Carcinoma, Non-Small-Cell Lung 46Lung Neoplasms 19Melanoma 18Neoplasm Metastasis 16Carcinoma, Hepatocellular 15Neoplasms 13Esophageal Neoplasms 12Squamous Cell Carcinoma of Head and Neck 10Colorectal Neoplasms 9Breast Neoplasms 9Head and Neck Neoplasms 8Stomach Neoplasms 6Rectal Neoplasms 6Esophageal Squamous Cell Carcinoma 6Carcinoma, Renal Cell 6Brain Neoplasms 6Small Cell Lung Carcinoma 5Recurrence 5Pancreatic Neoplasms 5Uterine Cervical Neoplasms 4Triple Negative Breast Neoplasms 4Sarcoma 4Precursor Cell Lymphoblastic Leukemia-Lymphoma 4Multiple Myeloma 4Liver Neoplasms 4Glioblastoma 4Cholangiocarcinoma 4Prostatic Neoplasms 3Nasopharyngeal Carcinoma 3Leukemia, Myelogenous, Chronic, BCR-ABL Positive 3

Interventions

Cyclophosphamide 101Etoposide 60Carboplatin 55Vincristine 51Filgrastim 49Topotecan 44Temozolomide 44Melphalan 44Isotretinoin 44Doxorubicin 44Irinotecan 42Cisplatin 353-Iodobenzylguanidine 34Peripheral Blood Stem Cell Transplantation 31dinutuximab 30Granulocyte Colony-Stimulating Factor 30Radiotherapy 29sargramostim 28Granulocyte-Macrophage Colony-Stimulating Factor 25Busulfan 22Magnetic Resonance Spectroscopy 19aldesleukin 18Thiotepa 18fludarabine 17Interleukin-2 17humanized 3F8 anti-GD2 monoclonal antibody 16etoposide phosphate 16naxitamab 15Ifosfamide 15Biopsy 13

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Neuroblastoma × Immunotherapy × Clear all
NCT06485947 2025-07-08

DBPilot

Princess Maxima Center for Pediatric Oncology

Phase 1 Recruiting
38 enrolled
CNS

Neuroblastoma

NCT00186862 2008-06-03

Gene Modified Allogeneic Neuroblastoma Cells For Treatment of Relapsed/Refractory Neuroblastoma

St. Jude Children's Research Hospital

Phase 1 Completed
24 enrolled
CNS

Neuroblastoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡